School of Medicine
Showing 101-110 of 121 Results
Clinical Associate Professor, Medicine - Pulmonary & Critical Care Medicine
Current Research and Scholarly Interests Drugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, acute kidney injury in pulmonary arterial hypertension
Andre Kumar MD, MEd
Clinical Assistant Professor, Medicine
Bio Andre Kumar earned his MD degree from Tulane University in New Orleans, Louisiana. He completed his residency and chief residency in internal medicine at Stanford University. He is currently a clinical assistant professor in the Stanford Division of Hospital Medicine.
Dr. Kumar is passionate about medical education and how to improve physician training. He earned a Master's in Education from Stanford University (2019) and is a 2019-2020 fellow for the Rathmann Medical Education Fellowship. His educational interests include educational technology, curriculum design, and leveraging educational outcomes research to improve curricula. His professional interests include clinical reasoning, bedside ultrasonography, and the doctor-patient relationship. As a resident, he developed the Stanford Hospitalist Advanced Practice and Education (SHAPE) Program, which was the first resident-run hospitalist training track in the country. He currently serves as the director for the SHAPE Program, as well as co-director for the Advanced Clinical Skills course in the Stanford School of Medicine. He is currently the PI for one of the largest randomized-controlled educational studies on the medical campus.
List of pubmed articles: https://www.ncbi.nlm.nih.gov/pubmed/?term=andre+kumar
Postdoctoral Research Fellow, Infectious Diseases
Current Research and Scholarly Interests The goal of my research is to better understand virus-host protein interactions, and translate this knowledge into the development of novel, broad-spectrum, antiviral drugs
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Bio Dr Kumari?s clinical interests lie in taking care of patients with Hepatitis C , cirrhosis and complications, liver cancer and management of post transplant patients. Her research interests are doing Translational research in Portal Hypertension and its complications.
Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Kummar?s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.
Pamela L. Kunz
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Bio Dr. Kunz specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors (NETs). She has developed broad investigative programs in the field of neuroendocrine tumors (NETs), encompassing clinical trials, population sciences, and translational correlates. Stanford has a robust referral base for neuroendocrine tumors and has demonstrated successful accrual to clinical trials in this rare disease. She has been involved with the design, development and conduct of Phase I, II, and III clinical trials in this field. She holds a number of leadership positions in the field including Vice Chair of the Neuroendocrine Tumor Taskforce of the National Cancer institute and member of the NANETS Board of Directors. She also serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel and the NET Working Group of the Eastern Cooperative Oncology Group (ECOG) and is the founding Director of the Stanford Neuroendocrine Tumor Program, established in 2015.